Classification
Compound class	Peptide or derivative
Approved drug?	Yes (EMA & FDA (2014))

International Nonproprietary Names
INN number	INN
9686	elosulfase alfa

Synonyms

BMN 110 | rhGALNS | Vimizim®

Comments

Elosulfase alfa is a recombinant enzyme replacement therapy for galactosamine (N-acetyl)-6-sulfatase (GALNS, P34059) deficiency. The peptide is translated from the human cDNA expressed in CHO cells [1].

Database Links
CAS Registry No.	9025-60-9 (source: SciFinder)
GtoPdb PubChem SID	178103964
Search PubMed clinical trials	elosulfase alfa
Search PubMed titles	elosulfase alfa
Search PubMed titles/abstracts	elosulfase alfa
Wikipedia	Elosulfase_alfa